Analysis of Genetic Variants Associated with Levels of Immune Modulating Proteins for Impact on Alzheimer’s Disease Risk Reveal a Potential Role for SIGLEC14. Here, SIGLEC14 is linked to early-onset autosomal dominant Alzheimer disease.